Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot Study
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
The proportion of patients experiencing no vomiting and no nausea, without use of any rescue antiemetic medication(s), from days 2-10 following the radiation therapy (delayed RINV).
Measurements will be taken daily within this time with patient self-report nausea diaries.
Days 2-10 following radiotherapy
Edward Chow, MBBS PhD FRCPC
Odette Cancer Centre, Sunnybrook Health Sciences Centre
Canada: Health Canada